- Business Type:
- Manufacturer
- Year Established:
- 2009
- Total Revenue:
- US$2.5 Million - US$5 Million
- Main Markets:
Company Description
Henley specializes in the development and manufacture of APIs and intermediates. Our products have been exported to Asia, Europe and America for many years. The product list includes Pyrrolidine, Carvedilol, Ondansetron, Granisetron HCl, Naftopidil, Lisinopril, Bicalutamide, Toremifene Citrate, Levosulpiride, Phthalimide and its potassium salt, and intermediates.